President and CEO, Allozyne
Professor of Systems Biology, Columbia University
Co-Founder, Exelixis Inc., and Anadys Pharmaceuticals Inc.
Professor of Bioengineering, Stanford University
Director, Energy Biosciences Inst., UC Berkeley
President and CEO, Regulus Therapeutics
Managing Partner, Triathalon Medical Ventures Fund II
Co-Founder and former CEO, Intellikine
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Organovo Raises $6.5M, Lists on OTC, in Alternative Public Offering | Bruce V. Bigelow | 02/14/12 | San Diego | |
| In Development of Bio-Engineered Skin Tissue, Third Try is Charm for Advanced BioHealing | Bruce V. Bigelow | 12/23/09 | San Diego | |
| Page 1 of 1 | ||||
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.